Knight Therapeutics Statistics

Total Valuation

TSX:GUD has a market cap or net worth of CAD 600.70 million. The enterprise value is 588.80 million.

Market Cap	600.70M
Enterprise Value	588.80M

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:GUD has 99.29 million shares outstanding. The number of shares has decreased by -1.93% in one year.

Current Share Class	99.29M
Shares Outstanding	99.29M
Shares Change (YoY)	-1.93%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	22.93%
Owned by Institutions (%)	15.45%
Float	61.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	193.77
PS Ratio	1.45
PB Ratio	0.78
P/TBV Ratio	2.02
P/FCF Ratio	17.88
P/OCF Ratio	16.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.69, with an EV/FCF ratio of 17.53.

EV / Earnings	-168.57
EV / Sales	1.42
EV / EBITDA	13.69
EV / EBIT	n/a
EV / FCF	17.53

Financial Position

The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.14.

Current Ratio	2.62
Quick Ratio	1.63
Debt / Equity	0.14
Debt / EBITDA	2.47
Debt / FCF	3.16
Interest Coverage	-1.29

Financial Efficiency

Return on equity (ROE) is -0.45% and return on invested capital (ROIC) is -0.84%.

Return on Equity (ROE)	-0.45%
Return on Assets (ROA)	-0.72%
Return on Invested Capital (ROIC)	-0.84%
Return on Capital Employed (ROCE)	-1.29%
Revenue Per Employee	555,498
Profits Per Employee	-4,689
Employee Count	745
Asset Turnover	0.41
Inventory Turnover	1.84

Taxes

Income Tax	-6.56M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.87% in the last 52 weeks. The beta is 0.11, so TSX:GUD's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+12.87%
50-Day Moving Average	5.95
200-Day Moving Average	6.00
Relative Strength Index (RSI)	51.61
Average Volume (20 Days)	42,628

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:GUD had revenue of CAD 413.85 million and -3.49 million in losses. Loss per share was -0.04.

Revenue	413.85M
Gross Profit	175.86M
Operating Income	-11.52M
Pretax Income	-10.05M
Net Income	-3.49M
EBITDA	39.39M
EBIT	-11.52M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 118.14 million in cash and 106.24 million in debt, giving a net cash position of 11.90 million or 0.12 per share.

Cash & Cash Equivalents	118.14M
Total Debt	106.24M
Net Cash	11.90M
Net Cash Per Share	0.12
Equity (Book Value)	766.79M
Book Value Per Share	7.69
Working Capital	248.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 35.55 million and capital expenditures -1.96 million, giving a free cash flow of 33.59 million.

Operating Cash Flow	35.55M
Capital Expenditures	-1.96M
Free Cash Flow	33.59M
FCF Per Share	0.34

Full Cash Flow Statement

Margins

Gross margin is 42.49%, with operating and profit margins of -2.78% and -0.84%.

Gross Margin	42.49%
Operating Margin	-2.78%
Pretax Margin	-2.43%
Profit Margin	-0.84%
EBITDA Margin	9.52%
EBIT Margin	-2.78%
FCF Margin	8.12%

Dividends & Yields

TSX:GUD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.93%
Shareholder Yield	1.93%
Earnings Yield	-0.58%
FCF Yield	5.59%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:GUD has an Altman Z-Score of 2.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	3